Search PubMed⌕ Search

Biomedical subjects

W Cendrowski

Publications and source records attributed to W Cendrowski.

At least 55 records · Page 3Linked to original sources
PubMed1976

Penicillamine in multiple sclerosis. Therapeutic trial and design of uncontrolled pilot drug study.

Twenty-three patients with the chronic progressive or intermittent relapsing form of multiple sclerosis (MS) were treated with d-penicillamine over a period from 6 weeks to 12 months. Clinical effect was evaluated using Kurtzke's disability status scale with follow-up lasting from 7 weeks to 15 months. Fifteen patients remained unchanged, 7 became worse and 1 improved after the treatment. Administration of penicillamine to patients with MS resulted in an insignificant lowering of serum IgA, IgG and IgM levels. It is concluded that penicillamine neither prevented the occurrence of relapses nor slowed down the chronic progressive course of multiple sclerosis.

Adult↗
PubMed1976

Multiple sclerosis and childhood infections.

There is evidence that some event in childhood may determine risk of multiple sclerosis: Elevated titers to measles and other childhood infections suggest a childhood infection. Therefore, childhood infections reported by 30 patients with multiple sclerosis and matched controls were compared. Patients reported a childhood infection between 5 and 9 years (not simply exposure to an infection) more often than controls. The mean age of measles peaked somewhat later (age 7) in patients than in controls (age 4); this differnce approached statistical significance (p less than 0.1). Evidence that host response to measles is age-dependent was reviewed. It was proposed that age of measles (rather than the fact of injection) may influence the risk of developing multiple sclerosis.

Adolescent↗
PubMed1973

Serum measles antibodies in multiple sclerosis.

Serum haemagglutination inhibition/HI/antibody titres to measles virus were examined in 80 multiple sclerosis patients, their 20 sibs, in 990 healthy controls, and 25 control patients. The measles HI titres were significantly raised in the serum of multiple sclerosis patients compared with healthy controls. There was no statistical difference between the levels of HI antibody titres in multiple sclerosis patients and their sibs. The measles HI titres decreased significantly in older age groups of healthy controls, whereas an analogous drop was not found in the multiple sclerosis group. The levels of serum HI antibody titres did not correlate with the sex of patients with multiple sclerosis or the activity of the disease. In the CSF of six multiple sclerosis patients low titres of HI antibodies were detected, whereas none of eight control patients had measurable traces of measles antibodies in the CSF. The significance of these findings in the aetiology of multiple sclerosis is briefly discussed.

Adolescent↗